MedPath

The effect of oral beta blocker for analgesia and nociception index(ANI) monitoring

Not Applicable
Conditions
Diseases of the circulatory system
Registration Number
KCT0008082
Lead Sponsor
Chonnam National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1. American Society of Anesthesiology Physical Classification (ASA PS) 2 to 3 patients
2. Patients who voluntarily gave written consent to participate in this clinical trial

Exclusion Criteria

1. Patients diagnosed with arrhythmia
2. Patients with a pacemaker
3. Patients being treated for chronic pain
4. Patients diagnosed with autonomic nervous system diseases such as epilepsy
5. If anticholinergic drugs or vasoconstrictors were used before or during surgery
6. Patients judged unsuitable by other researchers

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in ANI monitor measurements at the same 4-time points between the two groups
Secondary Outcome Measures
NameTimeMethod
Blood pressure, pulse rate, effect site concentration of Remifentanil
© Copyright 2025. All Rights Reserved by MedPath